Cambridge tests jab with potential to end all Covid pandemics

Register and reap the benefits

Become a member of the HCSA to gain access to a variety of support tools and services.

Join us

Winter Conference 2021 Countdown

HCSA Job Board

All the latest NHS procurement job opportunities

See the latest jobs..

Professor Jonathan Heeney said the vaccine could also protect against other coronaviruses

Cambridge University has joined the race to develop a Covid-19 vaccine with human trials of a jab that would be delivered through the skin via a jet of air due to start in the autumn.

“Making a coronavirus vaccine that will protect us not only from this pandemic but the next one — that’s our goal,” Jonathan Heeney, head of the laboratory of viral zoonotics at the university, said.

The vaccine is being developed by DIOSynVax, a company founded by Professor Heeney, together with the University of Cambridge and the University Hospital Southampton NHS Foundation Trust. It will receive £1.9 million in government funding for the first human trial.

Most Covid vaccines in advanced clinical trials work by exposing people to the entire “spike protein”,


Read full article


Source: The Times
Author: Rhys Blakely, Science Correspondent